MedTrace Logo

Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina.

NCT03179527 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-06-07

No results posted yet for this study

Summary

This study evaluates the clinical efficacy of Shuanghe Decoction in the treatment of unstable angina. All of the patients will be divided into 2 arms randomly. One of the arms will be treated by conventional western medicine, and the other one will be treated by Shuanghe Decoction at the base of conventional western medicine.

Conditions

  • Unstable Angina

Interventions

DRUG

Anti-Platelet Drugs

Including aspirin and clopidogrel, etc

DRUG

Lipid Regulating Drugs

Mainly including statins

DRUG

Coronary Vasodilator

Mainly including nitrates

DRUG

Shuanghe Decoction

Mainly including Ginseng, Poria, Calamus, Cyperus, Salvia miltiorrhiza, Radix Polygalae etc.

Sponsors & Collaborators

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    collaborator OTHER

  • Jun Li

    lead OTHER

Principal Investigators

  • Jun Li, MD · Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-31
Primary Completion
2019-10-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03179527 on ClinicalTrials.gov